RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways

Glioblastoma (GBM) is a highly vascularized malignant tumor that depends on new blood vessel formation. Small molecules targeting the angiogenic process may be an effective anti-GBM therapeutic strategy. We previously demonstrated that RhoJ promoted the progression and invasion of GBM. RhoJ has also...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mei, Zhang, Chengfei, Zheng, Qian, Ma, Zhijie, Qi, Min, Di, Guangfu, Ling, Shizhang, Xu, Haojun, Qi, Bin, Yao, Chengyun, Xia, Hongping, Jiang, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771846/
https://www.ncbi.nlm.nih.gov/pubmed/35173528
http://dx.doi.org/10.7150/ijbs.65653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771846/
https://www.ncbi.nlm.nih.gov/pubmed/35173528
http://dx.doi.org/10.7150/ijbs.65653

Ejemplares similares